Clinical Trials Directory

Trials / Completed

CompletedNCT06291454

GCF Levels of Chemokines in Periodontitis

CCL19/MIP3beta and CCL20/MIP3alpha Levels in the Gingival Crevicular Fluid of the Patients With Stage III Grade B and C Periodontitis

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
Ordu University · Academic / Other
Sex
All
Age
22 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study aimed to determine CCL19/MIP3beta(β) and CCL20/MIP3alpha(α) in the gingival crevicular fluid (GCF) of the patients with different periodontitis phenotypes. A total of 72 individuals, 24 with Stage III Grade B periodontitis (Group 1), 24 with Stage III Grade C periodontitis (Group 2), and 24 periodontally healthy (control group) (Group 3), were included in the study. GCF and clinical periodontal parameters were obtained at baseline. MIP3β and MIP3α levels in GCF were determined by ELISA.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRoutine periodontal examinationIn all of the patients, the following indexes were used routinely for the periodontal examination: Sillness-Löe's plaque index (PI) (Silness \& Löe, 1964), Löe-Sillness's gingival index (GI)(Löe \& Silness, 1963), probing depth (PD) to measure the extent and severity of periodontal disease, clinical attachment level (CAL), and bleeding on probing (BOP)(Ainamo \& Bay, 1975) to determine activity. In addition, routine radiographic evaluations were performed to determine bone levels.GCF samples were collected using standardized filter papers.

Timeline

Start date
2023-01-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2024-03-04
Last updated
2024-03-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06291454. Inclusion in this directory is not an endorsement.